Gallagher Fiduciary Advisors, LLC Viatris Inc Transaction History

Gallagher Fiduciary Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $70.2 Million - $80.2 Million	-5,300,307 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $4.59 Million - $5.71 Million	-353,762 Reduced 6.26%	5,300,307 $75.7 Million
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $3.08 Million - $4.2 Million	-226,629 Reduced 3.85%	5,654,069 $79 Million
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $84.1 Million - $110 Million	5,880,698 New	5,880,698 $110 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Gallagher Fiduciary Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Gallagher Fiduciary Advisors, LLC with notifications on news.